Form 4: Catalyst Pharmaceuticals Director Patrick McEnany Donates Shares to Charity

Patrick McEnany, a Director and Chairman of the Board at Catalyst Pharmaceuticals, donated 5,100 shares of common stock to the Baptist Health South Florida Foundation.

Summary

• On August 22, 2024, Patrick J. McEnany, a Director and Chairman of the Board at Catalyst Pharmaceuticals, donated 5,100 shares of common stock to the Baptist Health South Florida Foundation.
• The donation was a charitable gift for which McEnany received no compensation.
• Following the transaction, McEnany beneficially owns 4,478,169 shares of Catalyst Pharmaceuticals.
• McEnany retains no control over the gifted shares, and this donation completes his planned donation to the charity.

Sentiment

Score: 7

Explanation: The document reflects a positive action (charitable donation) by a company director, which is generally viewed favorably. The transaction itself is straightforward and doesn't indicate any underlying issues with the company.

Positives

• The donation to the Baptist Health South Florida Foundation is a positive philanthropic action by Patrick McEnany.
• The completion of McEnany's planned donation to the charity indicates a fulfillment of his charitable commitments.

Management Comments

• Reporting Person retains no control over the shares gifted.
• This gift completes the Reporting Person's planned donation to this charity.

Industry Context

Charitable donations by company executives are not uncommon and can be viewed positively by the market, especially when the executive retains a significant stake in the company.

Comparison to Industry Standards

• Executive charitable giving is a common practice across various industries.
• Comparing McEnany's donation to similar donations by executives at comparable pharmaceutical companies would require further research into their individual philanthropic activities and holdings.
• Without specific data on peer group donations, it's difficult to benchmark this particular transaction against industry standards.

Stakeholder Impact

• The donation may have a minor positive impact on the Baptist Health South Florida Foundation.
• The donation is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors of Catalyst Pharmaceuticals.

Key Dates